Director, Medical Evidence Generation Lead Cell Therapy, AutoImmune Diseases
Bristol Myers Squibb
Summary
The Director, Medical Evidence Generation (MEG) Lead, MEG Cell Therapy (CT) at Bristol Myers Squibb supports evidence generation for the Cell Therapy portfolio, including Clinical Research Collaborations (CRCs), Medical Affairs Sponsored Studies (MAST), and Investigator-Sponsored Research Studies (ISRs), ensuring alignment with internal strategies to accelerate pipeline development. Key responsibilities include fostering relationships with thought leaders, managing the lifecycle of CRCs and ISRs, and addressing evidence gaps by partnering with academic and professional networks.
Job description
Responsibilities
- Facilitate collaborative exchange between BMS and thought leaders in community practice and academia, including scientific dialogue and representing BMS as a trusted, inclusive, and innovative industry collaborator and partner of choice
- Be accountable for delivering CRCs, ISRs, and/or MASTs from concept ideation to governance approval and throughout the study lifecycle, including protocol development, data review and internal/external presentation
- Act as point of contact for CRCs, ISRs, and/or MASTs within relevant teams to drive clinical trial conduct
- Design and drive strategies to accelerate the development of BMS's evidence generation pipeline leveraging external research platforms, technologies, and insights
- Align with and advise senior functional and therapeutic area leaders on new external opportunities that will inform strategy and influence decisions in the creation/refinement of integrated evidence generation plans
- Personally lead a limited number of high-visibility projects leveraging relevant disease subject matter expertise
- Contribute to the evolution of MEG Cell Therapy strategy and value proposition
Qualifications & Experience
- Advanced scientific degree (MD, PhD, PharmD or the equivalent) required with extensive, relevant scientific, and/or clinical experience
- At least 7 years of experience in pharmaceutical Clinical Development, Medical Affairs or relevant Clinical Development experience; previous clinical trial management and customer-facing role experience highly desirable
- Demonstrated ability to strategically analyze data generation opportunities with minimal supervision
- Demonstrated ability to develop and sustain high-performing relationships with external thought leaders and internal matrix stakeholders across the cell therapy organization
- Adeptness at building credibility with external investigators and collaborative partners competently balancing business and scientific acumen complemented by strong leadership behaviors, authenticity, agility, and an enterprise mindset
- Understanding of global healthcare systems and academic settings with a demonstrated ability to lead in ambiguous and changing healthcare/business environments
- Exceptional communication and interpersonal skills to influence decision-making at all levels of the organization
- In depth knowledge of overall project planning and project management of clinical trials
- Proven ability to partner effectively with colleagues across multiple functions and at all levels of the enterprise
- Exceptional interpersonal and communication skills appropriately flexing based on audience; expertly leverages effective communication and negotiation skills to influence decisions
- Experience in Hematology and/or Autoimmune Diseases preferred
- Expected travel is 30% - globally
Requirements
- Advanced scientific degree (MD, PhD, PharmD or equivalent) required
- Extensive relevant scientific and/or clinical experience
- At least 7 years of experience in pharmaceutical Clinical Development, Medical Affairs or relevant Clinical Development experience
- Previous clinical trial management and customer-facing role experience highly desirable
- Demonstrated ability to strategically analyze data generation opportunities with minimal supervision
- Demonstrated ability to develop and sustain high-performing relationships with external thought leaders and internal matrix stakeholders
- Adeptness at building credibility with external investigators and collaborative partners
- Strong leadership behaviors, authenticity, agility, and enterprise mindset
- Understanding of global healthcare systems and academic settings
- Exceptional communication and interpersonal skills
- In depth knowledge of project planning and project management of clinical trials
- Proven ability to partner effectively across multiple functions and levels
- Effective communication and negotiation skills
- Experience in Hematology and/or Autoimmune Diseases preferred
- Expected travel 30% globally
Benefits
- Medical, Dental & Vision
- Life & Disability Insurance
- Retirement Benefits
- Financial Protection Benefits
- Flexible Time Off
- 11 Paid Company Holidays
- Paid Sick Leave
- Volunteer Days
- Summer Hours Flexibility
- Global Shutdown
- Wellbeing Support
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.